November 26, 2018
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

Registration Now Open! NRG Oncology Semiannual Meeting in Phoenix.
Read more

Help Celebrate Our Birthday at the NRG Oncology Semiannual Meeting in Phoenix
We hope you can join us for the NRG Oncology Semiannual Meeting and Birthday Celebration, February 7 - 9, 2019 at the Phoenix Convention Center in Phoenix, AZ.
Registration deadline is January 14, 2019!

Our Gift to You

 It’s our birthday, and we are celebrating the reason for our success – our members! We are extending our birthday gift to you. In honor of our 5th birthday, NRG Oncology is waiving the registration fee for all NRG Oncology members. Please be sure to  Click here to register Today!

GOG-0278: Amendment 6; version date: October 31, 2018 (posted on NRG Oncology)

NRG-GY009: Amendment 6; version date: October 22, 2018 (posted on CTSU)

NRG-BR003, NRG-GI002, and NRG-GI004: Memorandum - Scheduling Protocol Therapy during the Holidays (posted to individual protocol pages on the CTSU website)

NRG-GI002: REMINDER!  Register for the GoToMeeting Amendment #1 discussion (posted on CTSU)

NRG-GI004: REMINDER!  There is still time to register for the WebEx on November 30. (posted on CTSU)

NRG-GY016: Fasting Blood Biospecimens memo (posted on CTSU)

Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus
Please note that the NRG Patient ID (e.g., AB###-GY###-#####) must be included on any copies of Form TR shipped to the NRG Biospecimen Bank-Columbus.

If the NRG Patient ID does not appear on the top, left of Form TR, please hand-complete the NRG Patient ID before sending the form to the NRG Biospecimen Bank-Columbus. Do not complete the NRG Patient ID for forms accompanying biospecimens shipped to laboratories other than the NRG Biospecimen Bank-Columbus.Please contact the NRG Biospecimen Bank-Columbus at if you need assistance or if you have additional questions.

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment
Please be advised that the data exchange between the Biospecimen Bank-Columbus and SDMC is undergoing refurbishment. During this time, biospecimen receipt information will not appear in Rave or SEDES. Biospecimen transmittal forms (i.e., Form SP and Form TR) will ultimately not appear as overdue during this time; however, there may be a brief period over the next several weeks during which forms may temporarily appear as overdue. If this should occur or if you experience any other issues, please notify Support at Sites should continue to return inquiries from Biospecimen Bank-Columbus staff regarding biospecimen receipt during this time.

NRG-LU002: A webinar will be held on November 29, 2018. Registration is now open. More information can be found under News. Read more

4. Children’s Oncology Group Protocol AGCT1531: “A Phase III Trial of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors” is open to patient entry. It is available on the CTSU menu with Dr. Allan Covens as NRG Champion. Please enroll your eligible patients to this important trial. Enrollment credited to NRG Oncology will count towards membership requirements.

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for December 5, 2018.


Safety updates have been issued for the following studies:





























#GivingTuesday - A global day of giving fueled by the power of social media and collaboration
As you make your plans for #givingtuesday, please consider NRG Oncology (@NRGonc) and helping us further our shared mission to improve the lives of cancer patients. Donate at:

NRG Oncology will be holding a webinar for NRG-LU002: Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial. The webinar will occur on Thursday, November 29, 2018 from 3-4pm ET.

Register at:

The webinar will be hosted by the NRG-LU002 Study Principal Investigator, Dr. Puneeth Iyengar of UT Southwestern Medical Center. There will be a question and answer session following the presentation. Please contact Angela LaPenta at with any questions.

In Memoriam – Nikolay Dimitrov, MD (1925-2018)

It is with sadness that we announce the passing of Dr. Nikolay Dimitrov, 93, on November 10, 2018. Dr. Dimitrov, Professor of Medicine Emeritus at Michigan State University, was a long-standing investigator with NSABP and more recently, a member of NRG Oncology. In 1981 he received the Eleanor Roosevelt Research Service Award from the National Cancer Institute.  He was designated as "Honorable Professor" by the Medical College of Xian, People's Republic of China, and was a recipient of the Michigan Association of Governing Boards' Distinguished Faculty Award. For many years he was devoted to clinical trials research, to mentoring colleagues, and to his patients, for whom he was a kind and caring physician.

NRG Oncology 2018 SABCS Annual Meeting Presentation Schedule
The SABCS Annual Meeting is being held December 4-8, 2018 in San Antonio, TX. The list of presentations by NRG Oncology researchers is posted on the NRG Oncology website.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

Coen JJ, Zhang P, Saylor PJ, Lee CT, Wu CL, Parker W, Lautenschlaeger T, Zietman AL, Efstathiou JA, Jani AB, Kucuk O, Souhami L, Rodgers JP, Sandler HM, Shipley WU. Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial. J Clin Oncol. 2018 Nov 15. Read more

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT.  Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2018 Nov 15. Read more

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings
American Society of Clinical Oncology (ASCO) GI; Jan 17-19, 2019; San Francisco, CA

San Antonio Breast Cancer Symposium (SABCS); Dec 4-8, 2018; San Antonio, TX

Upcoming Abstract Submission Deadlines
American Association for Cancer Research (AACR); Mar 29 - Apr 3, 2019; Atlanta, GA; LBA submission due Jan 10, 2019

American Brachytherapy Society (ABS); Jun 13-15, 2019; Miami, FL; due to publications committee Dec 28, 2018; meeting submission deadline Jan 11, 2019 4pm CT

American College of Radiology (ACR); May 18-22, 2019 ; Washington DC; due to publications committee Nov 30, 2018; meeting submission deadline Dec 14, 2018 5 pm

American Society of Colon and Rectal Surgeons (ASCRS); Jun 1-5, 2019; Cleveland, OH; meeting submission deadline Nov 27, 2018

Society for Clinical Trials (SCT); May 19-22, 2019; New Orleans, LA; meeting submission deadline Nov 30, 2018

Society of Gynecologic Oncology (SGO); Mar 16-19, 2019; Honolulu, HI; deadline for LBA Dec 5, 2018 to Jan 7, 2019

St. Gallen Breast Cancer Conference (SG-BCC); Mar 20-23, 2019; Vienna, Austria; due to publications committee Nov 30, 2018; meeting submission deadline Dec 15, 2018

NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from to
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address | Forward Email | Report Abuse